This letter to the editor relates to the study entitled "Tenofovir amibufenamide tenofovir alafenamide for treating chronic hepatitis B: A real-world study", which was recently published by Peng . Hepatitis B virus infection represents a significant health burden worldwide and can lead to cirrhosis and even liver cancer. The antiviral drugs currently used to treat patients with chronic hepatitis B infection still have many side effects, so it is crucial to identify safe and effective drugs to inhibit viral replication.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287400 | PMC |
http://dx.doi.org/10.3748/wjg.v30.i26.3261 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!